Updated September 1, 2024

​​

The spread of infectious diseases has occurred many times in the past, resulting in many deaths.

​

Infectious diseases are difficult to solve and are considered to be an eternal challenge for humankind. Many infectious diseases occur in poor living environments, and my previous experience with a JICA project led me to get involved in infectious diseases.

​

Infectious diseases can be transmitted through the air, droplets, or contact, but it is generally believed that about 80% of infections are caused by bacteria and viruses transmitted through contact. Therefore, if we can continuously block transmission, we can significantly reduce the number of infections.

​

Unlike conventional antibacterial agents, the newly developed antibacterial agent is a solid bactericidal agent, so it is characterized by its continuity, non-toxicity, and no elution, so there is no environmental impact. In the future, there are many possible uses for this product, not only in the medical field, but also in food hygiene management, water and air, etc., but we have decided to focus our business on infectious disease control.

​

The business model will be a licensing business centered on the supply of the antibacterial agent "AbedulAg+."​​